.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Supplemental Material: Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

December 24, 2020

Dolly Sharma, PhD, Jeffrey Wojtynek, PharmD, Kathleen M. Fox, PhD, Chelsea Cooper, PharmD, Igoni Dokubo, MD

Evidence-Based Oncology, February 2021, Volume 27, Issue 2

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.

Download Issue : February 2021